MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fneur.2026.1921538

Медицинская библиотека · Frontiers in neurology · 2026

Tenecteplase in acute ischemic stroke: an updated meta-analysis.

Almohammed Hussain, Morad Ahmed Salah, Bin Saddiq Bushra Wadi, Almuhaysin Fatimah Ibrahim, Al Zoabi Bayan Mohammed Khair, Aldawsari Wejdan Ahmed, Khan Tanveer Nidal, Thalib Husna Irfan, Alabdi Zainab

СтатьяМетаанализСистематический обзорПеревод в очереди

Аннотация

INTRODUCTION

Tenecteplase (TNK) has emerged as a promising alternative to alteplase (tPA) for intravenous thrombolysis in acute ischemic stroke (AIS). This study aimed to evaluate the efficacy and safety of TNK compared with tPA.

METHODS

Following the PRISMA 2020 guidelines, PubMed, Web of Science, Cochrane Central, EBSCO, and Scopus were systematically searched from inception through January 2026 to identify randomized controlled trials (RCTs) and observational studies comparing TNK with tPA in adults with AIS. Effect estimates were pooled using fixed- or random-effects models according to the degree of heterogeneity and were reported as risk ratios (RRs), odds ratios (ORs), or mean differences (MDs) with 95% confidence intervals (CIs).

RESULTS

Twenty-four studies (6 RCTs and 18 observational studies; total n = 20,592) involving patients with AIS were included. Compared with tPA, TNK was associated with a greater likelihood of excellent functional recovery (mRS 0-1) at 90 days (RR = 1.08; 95% CI: 1.01-1.15; p = 0.02) and a shorter door-to-needle time by an average of 4 min (MD = -4.20; 95% CI: -7.77 to -0.64; p = 0.02). Mortality was lower among patients treated with TNK (OR = 0.83; 95% CI: 0.73-0.94; p = 0.004). However, subgroup analyses restricted to RCTs showed no significant difference in mortality between the TNK and tPA groups (OR = 0.99; 95% CI: 0.82-1.21; p = 0.95).

CONCLUSION

TNK provides efficacy and safety profiles comparable to those of tPA while offering a greater likelihood of excellent functional recovery, faster treatment initiation, and lower mortality in observational studies. Further high-quality RCTs are warranted to confirm these findings.

SYSTEMATIC REVIEW REGISTRATION: CRD420251030320.

Для цитирования: Almohammed Hussain, Morad Ahmed Salah, Bin Saddiq Bushra Wadi, Almuhaysin Fatimah Ibrahim, Al Zoabi Bayan Mohammed Khair, Aldawsari Wejdan Ahmed, Khan Tanveer Nidal, Thalib Husna Irfan, Alabdi Zainab. Tenecteplase in acute ischemic stroke: an updated meta-analysis.. Frontiers in neurology. 2026. DOI: 10.3389/fneur.2026.1921538.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.